Related Experiment Videos
Colonic neoplastic polyps: biopsy is not efficient to exclude malignancy. The Trafford experience
1Department of Surgery, Trafford Healthcare NHS Trust, Manchester, UK.
Techniques in Coloproctology
|January 25, 2005
Summary
Polyp biopsies may miss malignancy. Comparing biopsies to whole polyp examination in 433 neoplastic polyps revealed 18.5% of cancerous polyps were initially missed, highlighting the risk of sampling error in colorectal polyp diagnosis.
Area of Science:
- Gastroenterology
- Surgical Pathology
- Colorectal Cancer Screening
Background:
- Colorectal polyps, particularly adenomas, are precursors to carcinoma.
- Accurate histological subtyping of polyps is crucial for patient management.
- Polyp biopsy is standard but carries a risk of sampling error.
Purpose of the Study:
- To quantify the sampling error in differentiating neoplastic polyps via biopsy versus total examination.
- To assess the diagnostic accuracy of polyp biopsy in detecting malignancy compared to complete polyp excision.
Main Methods:
- A comparative study involving 433 neoplastic polyps.
- Analysis of biopsy results versus examination of the entire polyp specimen.
- Evaluation of diagnostic discrepancies between partial and complete tissue assessment.
Main Results:
- 18.5% of carcinomatous polyps showed definitive malignant features only upon complete examination.
- Biopsy sampling led to a significant rate of false-negative results for malignancy in colorectal polyps.
- Variations in architectural patterns were observed between polyp biopsies and whole specimens.
Conclusions:
- Polyp biopsy is significantly less efficient than total polyp examination for diagnosing malignancy.
- A 18.5% false-negative rate underscores the limitations of biopsy in detecting cancerous colonic polyps.
- Special reporting templates are recommended for biopsied or incompletely excised polypoidal tumors.